Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Clinical trial NCT01173731 · COMPLETED

Trial details

NCT number: NCT01173731
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Dyskinesia, Drug-Induced Levodopa

Start date: 2010-10-01
Primary completion: 2013-10-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.